OpenAlex
PricingAboutJobs
Log inGet started
Work

Exenatide Improves Glycemic Control and Reduces Body Weight in Subjects with Type 2 Diabetes: A Dose-Ranging Study

HTML

Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Technology & Therapeutics
DOI: 10.1089/dia.2005.7.467
Authors: Terri Poon, Patric Nelson, Larry Shen, Michael Mihm, Kristin Taylor, Mark Fineman, Dennis Kim
Institution: Eli Lilly (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, type 2 diabetes, incretin mimetics, glycemic control, HbA1c, fasting blood glucose, postprandial blood glucose, weight loss, dose dependence, metformin, diet and exercise, drug tolerability, adverse events, nausea, vomiting, hypoglycemia, pharmacokinetics, pharmacodynamics, glucagon-like peptide-1
SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, Amylin Pharmaceuticals
OpenAlex ID: W1964478407
FWCI: 9.149
Cites: 49
Cited by: 108
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security